表紙
年間契約型資訊服務

生技仿製藥目錄:全球生技仿製藥開發平台追蹤調查

Biosimilar Index: Tracking the Biosimilar Development Landscape

出版商 FirstWord 商品編碼 298599
出版日期 年間契約型資訊服務 內容資訊 英文
價格
如有價格方面的疑問請按下「詢問」鍵來信查詢
Back to Top
生技仿製藥目錄:全球生技仿製藥開發平台追蹤調查 Biosimilar Index: Tracking the Biosimilar Development Landscape
出版日期: 年間契約型資訊服務內容資訊: 英文
簡介

本報告提供全球主要生技仿製藥的開發情形相關更新及極為詳細的分析,為您概述為以下內容。

生技仿製藥目錄:開發平台資料庫

資料庫的主要的內容

  • 參考產品品牌名
  • 適應症及參考產品的銷售額報告
  • 提案企業
  • 生技仿製藥開發企業
  • 開發企業的本部所在地
  • 治療層級
  • 主要指標
  • 應用形態·管理途徑
  • 臨床實驗情形
  • 全球行銷情形
  • 行銷協定·授權機會

生技仿製藥目錄:形勢檢討

  • 包含以下的最重要結構化資料
    • 參考產品的銷售額資料
    • 現在·未來市場的里程碑
    • 各主要產品的單一視點分析
    • 臨床實驗活動·開發階段的流程圖
  • 本服務引用臨床實驗登記、企業通訊、會議的議事記錄、仲介分析及社群媒體等廣泛高可信度情報來源
  • 知識豐富專家的強力說明與分析
  • Microsoft PowerPoint格式
目錄

A new force in biosimilar and NCB drug and market tracking

FirstView's Biosimilar Index is a new, comprehensive drug intelligence service which provides a robust, dynamically updated and highly-detailed insight into the status of leading biosimilar and NCB assets in development worldwide. Exhaustively referenced and sourced, it is one of the most comprehensive analyses of its type providing both on-going tracking of development and interpretation of the commercial and clinical significance.

Two class beating services in one subscription!

Biosimilar Index: Pipeline Database

The Biosimilars Index: Pipeline Database is checked daily. When a significant event happens, the database is updated, thereby ensuring you're up to date with current market dynamics. The database is provided as a dynamic MS Excel™ file with complete data and filter analysis tools included.

Available 24/7 through a secure password protected site, there are no limits on how frequently you can download the XLS file. Having access to the database enables you to see the whole biosimilar and NCB landscape across multiple classes and geographies

Essential details covered in the database include:

  • Brand name(s) of reference products
  • Indications and reported sales for the reference product
  • Originator company
  • Biosimilars development company
  • HQ location of development company
  • Therapy class
  • Key indication(s)
  • Mode of application and route of administration
  • Clinical trials status
  • Global marketing status
  • Marketing agreements and licensing opportunities

Powerful data with intuitive analysis tools

With Biosimilars Index: Pipeline Database at hand, you can effortlessly compare and contrast biosimilars in development by country, originator company, stage of development, condition and therapeutic area. The data is provided in MS Excel™ and comes with filters and search built in. The data can easily be exported to your own analytics package or data visualisation platform.

Biosimilar Index: Landscape Review

What's hot and what's not? The biosimilars sector is constantly evolving. Important research progress, commercial deals and product launches are regularly announced. The Biosimilar Index: Landscape Review strips away market rumour and speculation to tell you exactly what has happened and why it is important.

Published quarterly, the Review is based on the daily-updated research in the Biosimilar Index: Pipeline Database, enhanced by critical insights and understanding from biosimilars experts.

The benefits and features of the Biosimilar Index: Landscape Review...

  • Includes essential structured data including
    • Sales data for reference products
    • Current and future market milestones
    • Individual single view analysis for leading products
    • Clinical trial activities and flow charts of development phase.
  • The service draws on a wide-range of reliable information sources such as clinical trial registries, company communications, conference proceedings, broker analysis and social media.
  • Includes powerful interpretation and analysis by knowledgeable experts to ensure that developments are scrutinised and the implications highlighted.
  • Presented in MS PowerPoint™ to bring clarity to the extensive charting and tables provided which can be incorporated into your own presentations

Key benefits and features:

With Biosimilar Index you can...

  • Understand the biosimilar and NCB development landscape through comprehensive coverage of the pipelines of all major biosimilar developers worldwide
  • Drill down to discover the levels of potential biosimilar competition by therapy area, drug class status and geography
  • Establish the level of biosimilar competition for leading biologic brands
  • Learn which biosimilar developers are potential future competitors or collaborators
  • Identify the biosimilar and NCB portfolios of over 130 companies and discover the leaders in product development for which products/therapy areas
  • Know where the development hotspots are and what research is taking place.

The Biosimilar Index is feature rich...

  • Includes both structured data and commercial interpretation
  • The Biosimilar Index: Pipeline Database covers all significant biosimilar products and is updated daily. Available 24/7 in MS Excel™ with unlimited downloads which can be incorporated into your own analytics package or visualisation software
  • The Biosimilar Index: Landscape Review provides and insightful quarterly analysis which identifies the developments that are really important
  • Biosimilar Index is Informed by a wide-range of respected sources with expert internal and external inputs and oversight

A service for the whole industry

Whether you work in big pharma, a biosimilars development company, a clinical service organisation, a regulatory body or in commercial investment and finance, the Biosimilar Index provides a clear window on the world of biosimilar drugs and their developers.

With the Biosimilar Index you are always in the know!

Table of Contents

Introduction

Executive summary

Reference medicinal product data

Market milestones; Q1 2013 - Q1 2014

Potential future milestones; Q2 2014 - Q4 2014

Biosimilar programme analysis

  • Pipeline summary by molecule
  • Clinical trials by molecule

Appendix

  • Data sources
  • Definitions and terminology
  • Disclaimer

[139 slides]

List of Companies

  • AbbVie
  • Idec Pharmaceuticals
  • Sanofi
  • Genentech
  • Centocor
  • Immunex
  • Amgen Genentech
  • Kirin Holdings
  • Novo Nordisk
  • Biogen Idec
  • Eli Lilly
  • Sanofi
  • Novo Nordisk
Back to Top